223 related articles for article (PubMed ID: 31775826)
1. Differential regulation of Cav2.2 channel exon 37 variants by alternatively spliced μ-opioid receptors.
Gandini MA; Souza IA; Raval D; Xu J; Pan YX; Zamponi GW
Mol Brain; 2019 Nov; 12(1):98. PubMed ID: 31775826
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing in the C-terminus of CaV2.2 controls expression and gating of N-type calcium channels.
Castiglioni AJ; Raingo J; Lipscombe D
J Physiol; 2006 Oct; 576(Pt 1):119-34. PubMed ID: 16857708
[TBL] [Abstract][Full Text] [Related]
3. Voltage-Gated R-Type Calcium Channel Inhibition via Human μ-, δ-, and κ-opioid Receptors Is Voltage-Independently Mediated by Gβγ Protein Subunits.
Berecki G; Motin L; Adams DJ
Mol Pharmacol; 2016 Jan; 89(1):187-96. PubMed ID: 26490245
[TBL] [Abstract][Full Text] [Related]
4. Agonist-induced, G protein-dependent and -independent down-regulation of the mu opioid receptor. The receptor is a direct substrate for protein-tyrosine kinase.
Pak Y; O'Dowd BF; Wang JB; George SR
J Biol Chem; 1999 Sep; 274(39):27610-6. PubMed ID: 10488100
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors.
Raingo J; Castiglioni AJ; Lipscombe D
Nat Neurosci; 2007 Mar; 10(3):285-92. PubMed ID: 17293861
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing in the voltage-sensing region of N-Type CaV2.2 channels modulates channel kinetics.
Lin Y; McDonough SI; Lipscombe D
J Neurophysiol; 2004 Nov; 92(5):2820-30. PubMed ID: 15201306
[TBL] [Abstract][Full Text] [Related]
7. C-terminal splice variants of P/Q-type Ca
Hirano M; Takada Y; Wong CF; Yamaguchi K; Kotani H; Kurokawa T; Mori MX; Snutch TP; Ronjat M; De Waard M; Mori Y
J Biol Chem; 2017 Jun; 292(22):9365-9381. PubMed ID: 28377503
[TBL] [Abstract][Full Text] [Related]
8. A118G Mu Opioid Receptor polymorphism increases inhibitory effects on CaV2.2 channels.
Lopez Soto EJ; Raingo J
Neurosci Lett; 2012 Aug; 523(2):190-4. PubMed ID: 22796651
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing matters: N-type calcium channels in nociceptors.
Lipscombe D; Raingo J
Channels (Austin); 2007; 1(4):225-7. PubMed ID: 18708749
[TBL] [Abstract][Full Text] [Related]
10. Involvement of mouse μ-opioid receptor splice variants in the spinal antinociception induced by the dermorphin tetrapeptide analog amidino-TAPA.
Mizoguchi H; Watanabe C; Higashiya T; Takeda S; Moriyama K; Yonezawa A; Sato T; Komatsu T; Sakurada T; Sakurada S
Eur J Pharmacol; 2011 Jan; 651(1-3):66-72. PubMed ID: 21047509
[TBL] [Abstract][Full Text] [Related]
11. Interaction via a key tryptophan in the I-II linker of N-type calcium channels is required for beta1 but not for palmitoylated beta2, implicating an additional binding site in the regulation of channel voltage-dependent properties.
Leroy J; Richards MW; Butcher AJ; Nieto-Rostro M; Pratt WS; Davies A; Dolphin AC
J Neurosci; 2005 Jul; 25(30):6984-96. PubMed ID: 16049174
[TBL] [Abstract][Full Text] [Related]
12. Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P.
Xu J; Xu M; Bolan E; Gilbert AK; Pasternak GW; Pan YX
Synapse; 2014 Apr; 68(4):144-52. PubMed ID: 24375714
[TBL] [Abstract][Full Text] [Related]
13. Mu-opioid and GABA(B) receptors modulate different types of Ca2+ currents in rat nodose ganglion neurons.
Rusin KI; Moises HC
Neuroscience; 1998 Aug; 85(3):939-56. PubMed ID: 9639286
[TBL] [Abstract][Full Text] [Related]
14. Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
Doyle GA; Sheng XR; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
Gene; 2007 Jun; 395(1-2):98-107. PubMed ID: 17398041
[TBL] [Abstract][Full Text] [Related]
15. Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1.
Narayan A; Hunkele A; Xu J; Bassoni DL; Pasternak GW; Pan YX
Cell Mol Neurobiol; 2021 Jul; 41(5):1059-1074. PubMed ID: 33033993
[TBL] [Abstract][Full Text] [Related]
16. Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activation.
Berecki G; McArthur JR; Cuny H; Clark RJ; Adams DJ
J Gen Physiol; 2014 Apr; 143(4):465-79. PubMed ID: 24688019
[TBL] [Abstract][Full Text] [Related]
17. Alternative Splicing in Ca(V)2.2 Regulates Neuronal Trafficking via Adaptor Protein Complex-1 Adaptor Protein Motifs.
Macabuag N; Dolphin AC
J Neurosci; 2015 Oct; 35(43):14636-52. PubMed ID: 26511252
[TBL] [Abstract][Full Text] [Related]
18. Functional compartmentalization of opioid desensitization in primary sensory neurons.
Samoriski GM; Gross RA
J Pharmacol Exp Ther; 2000 Aug; 294(2):500-9. PubMed ID: 10900225
[TBL] [Abstract][Full Text] [Related]
19. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG
Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
[TBL] [Abstract][Full Text] [Related]
20. µ-Opioid receptors inhibit the exercise pressor reflex by closing N-type calcium channels but not by opening GIRK channels in rats.
Estrada JA; Kaufman MP
Am J Physiol Regul Integr Comp Physiol; 2018 May; 314(5):R693-R699. PubMed ID: 29341826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]